COVID-19 Impact on Global Recombinant Therapeutic Protein, Market Insights and Forecast to 2026

COVID-19 Impact on Global Recombinant Therapeutic Protein, Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Recombinant Therapeutic Protein Product Introduction
1.2 Market Segments
1.3 Key Recombinant Therapeutic Protein Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Recombinant Therapeutic Protein Market Size Growth Rate by Type
1.4.2 Recombinant Human Collage
1.4.3 Recombinant Human Serum Albumin
1.5 Market by Application
1.5.1 Global Recombinant Therapeutic Protein Market Size Growth Rate by Application
1.5.2 Medicine
1.5.3 Scientific Research
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Recombinant Therapeutic Protein Industry Impact
1.6.1 How the Covid-19 is Affecting the Recombinant Therapeutic Protein Industry
1.6.1.1 Recombinant Therapeutic Protein Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Recombinant Therapeutic Protein Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Recombinant Therapeutic Protein Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Recombinant Therapeutic Protein Market Size Estimates and Forecasts
2.1.1 Global Recombinant Therapeutic Protein Revenue 2015-2026
2.1.2 Global Recombinant Therapeutic Protein Sales 2015-2026
2.2 Recombinant Therapeutic Protein Market Size by Region: 2020 Versus 2026
2.2.1 Global Recombinant Therapeutic Protein Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Recombinant Therapeutic Protein Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Recombinant Therapeutic Protein Competitor Landscape by Players
3.1 Recombinant Therapeutic Protein Sales by Manufacturers
3.1.1 Recombinant Therapeutic Protein Sales by Manufacturers (2015-2020)
3.1.2 Recombinant Therapeutic Protein Sales Market Share by Manufacturers (2015-2020)
3.2 Recombinant Therapeutic Protein Revenue by Manufacturers
3.2.1 Recombinant Therapeutic Protein Revenue by Manufacturers (2015-2020)
3.2.2 Recombinant Therapeutic Protein Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Recombinant Therapeutic Protein Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Recombinant Therapeutic Protein Revenue in 2019
3.2.5 Global Recombinant Therapeutic Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Recombinant Therapeutic Protein Price by Manufacturers
3.4 Recombinant Therapeutic Protein Manufacturing Base Distribution, Product Types
3.4.1 Recombinant Therapeutic Protein Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Recombinant Therapeutic Protein Product Type
3.4.3 Date of International Manufacturers Enter into Recombinant Therapeutic Protein Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Recombinant Therapeutic Protein Market Size by Type (2015-2020)
4.1.1 Global Recombinant Therapeutic Protein Sales by Type (2015-2020)
4.1.2 Global Recombinant Therapeutic Protein Revenue by Type (2015-2020)
4.1.3 Recombinant Therapeutic Protein Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Recombinant Therapeutic Protein Market Size Forecast by Type (2021-2026)
4.2.1 Global Recombinant Therapeutic Protein Sales Forecast by Type (2021-2026)
4.2.2 Global Recombinant Therapeutic Protein Revenue Forecast by Type (2021-2026)
4.2.3 Recombinant Therapeutic Protein Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Recombinant Therapeutic Protein Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Recombinant Therapeutic Protein Market Size by Application (2015-2020)
5.1.1 Global Recombinant Therapeutic Protein Sales by Application (2015-2020)
5.1.2 Global Recombinant Therapeutic Protein Revenue by Application (2015-2020)
5.1.3 Recombinant Therapeutic Protein Price by Application (2015-2020)
5.2 Recombinant Therapeutic Protein Market Size Forecast by Application (2021-2026)
5.2.1 Global Recombinant Therapeutic Protein Sales Forecast by Application (2021-2026)
5.2.2 Global Recombinant Therapeutic Protein Revenue Forecast by Application (2021-2026)
5.2.3 Global Recombinant Therapeutic Protein Price Forecast by Application (2021-2026)
6 North America
6.1 North America Recombinant Therapeutic Protein by Country
6.1.1 North America Recombinant Therapeutic Protein Sales by Country
6.1.2 North America Recombinant Therapeutic Protein Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Recombinant Therapeutic Protein Market Facts & Figures by Type
6.3 North America Recombinant Therapeutic Protein Market Facts & Figures by Application
7 Europe
7.1 Europe Recombinant Therapeutic Protein by Country
7.1.1 Europe Recombinant Therapeutic Protein Sales by Country
7.1.2 Europe Recombinant Therapeutic Protein Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Recombinant Therapeutic Protein Market Facts & Figures by Type
7.3 Europe Recombinant Therapeutic Protein Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Recombinant Therapeutic Protein by Region
8.1.1 Asia Pacific Recombinant Therapeutic Protein Sales by Region
8.1.2 Asia Pacific Recombinant Therapeutic Protein Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Recombinant Therapeutic Protein Market Facts & Figures by Type
8.3 Asia Pacific Recombinant Therapeutic Protein Market Facts & Figures by Application
9 Latin America
9.1 Latin America Recombinant Therapeutic Protein by Country
9.1.1 Latin America Recombinant Therapeutic Protein Sales by Country
9.1.2 Latin America Recombinant Therapeutic Protein Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Recombinant Therapeutic Protein Market Facts & Figures by Type
9.3 Central & South America Recombinant Therapeutic Protein Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Recombinant Therapeutic Protein by Country
10.1.1 Middle East and Africa Recombinant Therapeutic Protein Sales by Country
10.1.2 Middle East and Africa Recombinant Therapeutic Protein Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Recombinant Therapeutic Protein Market Facts & Figures by Type
10.3 Middle East and Africa Recombinant Therapeutic Protein Market Facts & Figures by Application
11 Company Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Corporation Information
11.1.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.1.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Boehringer Ingelheim Recombinant Therapeutic Protein Products Offered
11.1.5 Boehringer Ingelheim Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Corporation Information
11.2.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
11.2.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bristol-Myers Squibb Recombinant Therapeutic Protein Products Offered
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Celldex Therapeutics
11.3.1 Celldex Therapeutics Corporation Information
11.3.2 Celldex Therapeutics Description, Business Overview and Total Revenue
11.3.3 Celldex Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Celldex Therapeutics Recombinant Therapeutic Protein Products Offered
11.3.5 Celldex Therapeutics Recent Development
11.4 Eli Liily
11.4.1 Eli Liily Corporation Information
11.4.2 Eli Liily Description, Business Overview and Total Revenue
11.4.3 Eli Liily Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Eli Liily Recombinant Therapeutic Protein Products Offered
11.4.5 Eli Liily Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Corporation Information
11.5.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.5.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.5.4 GlaxoSmithKline Recombinant Therapeutic Protein Products Offered
11.5.5 GlaxoSmithKline Recent Development
11.6 Merck
11.6.1 Merck Corporation Information
11.6.2 Merck Description, Business Overview and Total Revenue
11.6.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Merck Recombinant Therapeutic Protein Products Offered
11.6.5 Merck Recent Development
11.7 Novartis
11.7.1 Novartis Corporation Information
11.7.2 Novartis Description, Business Overview and Total Revenue
11.7.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Novartis Recombinant Therapeutic Protein Products Offered
11.7.5 Novartis Recent Development
11.8 Regeneron Pharmaceuticals
11.8.1 Regeneron Pharmaceuticals Corporation Information
11.8.2 Regeneron Pharmaceuticals Description, Business Overview and Total Revenue
11.8.3 Regeneron Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Products Offered
11.8.5 Regeneron Pharmaceuticals Recent Development
11.9 Roche
11.9.1 Roche Corporation Information
11.9.2 Roche Description, Business Overview and Total Revenue
11.9.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Roche Recombinant Therapeutic Protein Products Offered
11.9.5 Roche Recent Development
11.10 Takeda
11.10.1 Takeda Corporation Information
11.10.2 Takeda Description, Business Overview and Total Revenue
11.10.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Takeda Recombinant Therapeutic Protein Products Offered
11.10.5 Takeda Recent Development
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Corporation Information
11.1.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.1.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Boehringer Ingelheim Recombinant Therapeutic Protein Products Offered
11.1.5 Boehringer Ingelheim Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Recombinant Therapeutic Protein Market Estimates and Projections by Region
12.1.1 Global Recombinant Therapeutic Protein Sales Forecast by Regions 2021-2026
12.1.2 Global Recombinant Therapeutic Protein Revenue Forecast by Regions 2021-2026
12.2 North America Recombinant Therapeutic Protein Market Size Forecast (2021-2026)
12.2.1 North America: Recombinant Therapeutic Protein Sales Forecast (2021-2026)
12.2.2 North America: Recombinant Therapeutic Protein Revenue Forecast (2021-2026)
12.2.3 North America: Recombinant Therapeutic Protein Market Size Forecast by Country (2021-2026)
12.3 Europe Recombinant Therapeutic Protein Market Size Forecast (2021-2026)
12.3.1 Europe: Recombinant Therapeutic Protein Sales Forecast (2021-2026)
12.3.2 Europe: Recombinant Therapeutic Protein Revenue Forecast (2021-2026)
12.3.3 Europe: Recombinant Therapeutic Protein Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Recombinant Therapeutic Protein Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Recombinant Therapeutic Protein Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Recombinant Therapeutic Protein Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Recombinant Therapeutic Protein Market Size Forecast by Region (2021-2026)
12.5 Latin America Recombinant Therapeutic Protein Market Size Forecast (2021-2026)
12.5.1 Latin America: Recombinant Therapeutic Protein Sales Forecast (2021-2026)
12.5.2 Latin America: Recombinant Therapeutic Protein Revenue Forecast (2021-2026)
12.5.3 Latin America: Recombinant Therapeutic Protein Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Recombinant Therapeutic Protein Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Recombinant Therapeutic Protein Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Recombinant Therapeutic Protein Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Recombinant Therapeutic Protein Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Recombinant Therapeutic Protein Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Recombinant Therapeutic Protein Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Recombinant Therapeutic Protein Market Segments
Table 2. Ranking of Global Top Recombinant Therapeutic Protein Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Recombinant Therapeutic Protein Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Recombinant Human Collage
Table 5. Major Manufacturers of Recombinant Human Serum Albumin
Table 6. COVID-19 Impact Global Market: (Four Recombinant Therapeutic Protein Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Recombinant Therapeutic Protein Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Recombinant Therapeutic Protein Players to Combat Covid-19 Impact
Table 11. Global Recombinant Therapeutic Protein Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Recombinant Therapeutic Protein Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Recombinant Therapeutic Protein Sales by Regions 2015-2020 (K MT)
Table 14. Global Recombinant Therapeutic Protein Sales Market Share by Regions (2015-2020)
Table 15. Global Recombinant Therapeutic Protein Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Recombinant Therapeutic Protein Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Recombinant Therapeutic Protein Sales Share by Manufacturers (2015-2020)
Table 18. Global Recombinant Therapeutic Protein Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Recombinant Therapeutic Protein by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Therapeutic Protein as of 2019)
Table 20. Recombinant Therapeutic Protein Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Recombinant Therapeutic Protein Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Recombinant Therapeutic Protein Price (2015-2020) (USD/MT)
Table 23. Recombinant Therapeutic Protein Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Recombinant Therapeutic Protein Product Type
Table 25. Date of International Manufacturers Enter into Recombinant Therapeutic Protein Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Recombinant Therapeutic Protein Sales by Type (2015-2020) (K MT)
Table 28. Global Recombinant Therapeutic Protein Sales Share by Type (2015-2020)
Table 29. Global Recombinant Therapeutic Protein Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Recombinant Therapeutic Protein Revenue Share by Type (2015-2020)
Table 31. Recombinant Therapeutic Protein Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Recombinant Therapeutic Protein Sales by Application (2015-2020) (K MT)
Table 33. Global Recombinant Therapeutic Protein Sales Share by Application (2015-2020)
Table 34. North America Recombinant Therapeutic Protein Sales by Country (2015-2020) (K MT)
Table 35. North America Recombinant Therapeutic Protein Sales Market Share by Country (2015-2020)
Table 36. North America Recombinant Therapeutic Protein Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Recombinant Therapeutic Protein Revenue Market Share by Country (2015-2020)
Table 38. North America Recombinant Therapeutic Protein Sales by Type (2015-2020) (K MT)
Table 39. North America Recombinant Therapeutic Protein Sales Market Share by Type (2015-2020)
Table 40. North America Recombinant Therapeutic Protein Sales by Application (2015-2020) (K MT)
Table 41. North America Recombinant Therapeutic Protein Sales Market Share by Application (2015-2020)
Table 42. Europe Recombinant Therapeutic Protein Sales by Country (2015-2020) (K MT)
Table 43. Europe Recombinant Therapeutic Protein Sales Market Share by Country (2015-2020)
Table 44. Europe Recombinant Therapeutic Protein Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Recombinant Therapeutic Protein Revenue Market Share by Country (2015-2020)
Table 46. Europe Recombinant Therapeutic Protein Sales by Type (2015-2020) (K MT)
Table 47. Europe Recombinant Therapeutic Protein Sales Market Share by Type (2015-2020)
Table 48. Europe Recombinant Therapeutic Protein Sales by Application (2015-2020) (K MT)
Table 49. Europe Recombinant Therapeutic Protein Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Recombinant Therapeutic Protein Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Recombinant Therapeutic Protein Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Recombinant Therapeutic Protein Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Recombinant Therapeutic Protein Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Recombinant Therapeutic Protein Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Recombinant Therapeutic Protein Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Recombinant Therapeutic Protein Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Recombinant Therapeutic Protein Sales Market Share by Application (2015-2020)
Table 58. Latin America Recombinant Therapeutic Protein Sales by Country (2015-2020) (K MT)
Table 59. Latin America Recombinant Therapeutic Protein Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Recombinant Therapeutic Protein Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Recombinant Therapeutic Protein Revenue Market Share by Country (2015-2020)
Table 62. Latin America Recombinant Therapeutic Protein Sales by Type (2015-2020) (K MT)
Table 63. Latin America Recombinant Therapeutic Protein Sales Market Share by Type (2015-2020)
Table 64. Latin America Recombinant Therapeutic Protein Sales by Application (2015-2020) (K MT)
Table 65. Latin America Recombinant Therapeutic Protein Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Recombinant Therapeutic Protein Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Recombinant Therapeutic Protein Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Recombinant Therapeutic Protein Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Recombinant Therapeutic Protein Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Recombinant Therapeutic Protein Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Recombinant Therapeutic Protein Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Recombinant Therapeutic Protein Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Recombinant Therapeutic Protein Sales Market Share by Application (2015-2020)
Table 74. Boehringer Ingelheim Corporation Information
Table 75. Boehringer Ingelheim Description and Major Businesses
Table 76. Boehringer Ingelheim Recombinant Therapeutic Protein Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Boehringer Ingelheim Product
Table 78. Boehringer Ingelheim Recent Development
Table 79. Bristol-Myers Squibb Corporation Information
Table 80. Bristol-Myers Squibb Description and Major Businesses
Table 81. Bristol-Myers Squibb Recombinant Therapeutic Protein Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Bristol-Myers Squibb Product
Table 83. Bristol-Myers Squibb Recent Development
Table 84. Celldex Therapeutics Corporation Information
Table 85. Celldex Therapeutics Description and Major Businesses
Table 86. Celldex Therapeutics Recombinant Therapeutic Protein Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Celldex Therapeutics Product
Table 88. Celldex Therapeutics Recent Development
Table 89. Eli Liily Corporation Information
Table 90. Eli Liily Description and Major Businesses
Table 91. Eli Liily Recombinant Therapeutic Protein Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Eli Liily Product
Table 93. Eli Liily Recent Development
Table 94. GlaxoSmithKline Corporation Information
Table 95. GlaxoSmithKline Description and Major Businesses
Table 96. GlaxoSmithKline Recombinant Therapeutic Protein Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. GlaxoSmithKline Product
Table 98. GlaxoSmithKline Recent Development
Table 99. Merck Corporation Information
Table 100. Merck Description and Major Businesses
Table 101. Merck Recombinant Therapeutic Protein Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Merck Product
Table 103. Merck Recent Development
Table 104. Novartis Corporation Information
Table 105. Novartis Description and Major Businesses
Table 106. Novartis Recombinant Therapeutic Protein Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Novartis Product
Table 108. Novartis Recent Development
Table 109. Regeneron Pharmaceuticals Corporation Information
Table 110. Regeneron Pharmaceuticals Description and Major Businesses
Table 111. Regeneron Pharmaceuticals Recombinant Therapeutic Protein Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Regeneron Pharmaceuticals Product
Table 113. Regeneron Pharmaceuticals Recent Development
Table 114. Roche Corporation Information
Table 115. Roche Description and Major Businesses
Table 116. Roche Recombinant Therapeutic Protein Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Roche Product
Table 118. Roche Recent Development
Table 119. Takeda Corporation Information
Table 120. Takeda Description and Major Businesses
Table 121. Takeda Recombinant Therapeutic Protein Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Takeda Product
Table 123. Takeda Recent Development
Table 124. Global Recombinant Therapeutic Protein Sales Forecast by Regions (2021-2026) (K MT)
Table 125. Global Recombinant Therapeutic Protein Sales Market Share Forecast by Regions (2021-2026)
Table 126. Global Recombinant Therapeutic Protein Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 127. Global Recombinant Therapeutic Protein Revenue Market Share Forecast by Regions (2021-2026)
Table 128. North America: Recombinant Therapeutic Protein Sales Forecast by Country (2021-2026) (K MT)
Table 129. North America: Recombinant Therapeutic Protein Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Europe: Recombinant Therapeutic Protein Sales Forecast by Country (2021-2026) (K MT)
Table 131. Europe: Recombinant Therapeutic Protein Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Asia Pacific: Recombinant Therapeutic Protein Sales Forecast by Region (2021-2026) (K MT)
Table 133. Asia Pacific: Recombinant Therapeutic Protein Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Latin America: Recombinant Therapeutic Protein Sales Forecast by Country (2021-2026) (K MT)
Table 135. Latin America: Recombinant Therapeutic Protein Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Middle East and Africa: Recombinant Therapeutic Protein Sales Forecast by Country (2021-2026) (K MT)
Table 137. Middle East and Africa: Recombinant Therapeutic Protein Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Market Risks
Table 141. Main Points Interviewed from Key Recombinant Therapeutic Protein Players
Table 142. Recombinant Therapeutic Protein Customers List
Table 143. Recombinant Therapeutic Protein Distributors List
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Therapeutic Protein Product Picture
Figure 2. Global Recombinant Therapeutic Protein Sales Market Share by Type in 2020 & 2026
Figure 3. Recombinant Human Collage Product Picture
Figure 4. Recombinant Human Serum Albumin Product Picture
Figure 5. Global Recombinant Therapeutic Protein Sales Market Share by Application in 2020 & 2026
Figure 6. Medicine
Figure 7. Scientific Research
Figure 8. Others
Figure 9. Recombinant Therapeutic Protein Report Years Considered
Figure 10. Global Recombinant Therapeutic Protein Market Size 2015-2026 (US$ Million)
Figure 11. Global Recombinant Therapeutic Protein Sales 2015-2026 (K MT)
Figure 12. Global Recombinant Therapeutic Protein Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Recombinant Therapeutic Protein Sales Market Share by Region (2015-2020)
Figure 14. Global Recombinant Therapeutic Protein Sales Market Share by Region in 2019
Figure 15. Global Recombinant Therapeutic Protein Revenue Market Share by Region (2015-2020)
Figure 16. Global Recombinant Therapeutic Protein Revenue Market Share by Region in 2019
Figure 17. Global Recombinant Therapeutic Protein Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Recombinant Therapeutic Protein Revenue in 2019
Figure 19. Recombinant Therapeutic Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Recombinant Therapeutic Protein Sales Market Share by Type (2015-2020)
Figure 21. Global Recombinant Therapeutic Protein Sales Market Share by Type in 2019
Figure 22. Global Recombinant Therapeutic Protein Revenue Market Share by Type (2015-2020)
Figure 23. Global Recombinant Therapeutic Protein Revenue Market Share by Type in 2019
Figure 24. Global Recombinant Therapeutic Protein Market Share by Price Range (2015-2020)
Figure 25. Global Recombinant Therapeutic Protein Sales Market Share by Application (2015-2020)
Figure 26. Global Recombinant Therapeutic Protein Sales Market Share by Application in 2019
Figure 27. Global Recombinant Therapeutic Protein Revenue Market Share by Application (2015-2020)
Figure 28. Global Recombinant Therapeutic Protein Revenue Market Share by Application in 2019
Figure 29. North America Recombinant Therapeutic Protein Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Recombinant Therapeutic Protein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Recombinant Therapeutic Protein Sales Market Share by Country in 2019
Figure 32. North America Recombinant Therapeutic Protein Revenue Market Share by Country in 2019
Figure 33. U.S. Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Recombinant Therapeutic Protein Market Share by Type in 2019
Figure 38. North America Recombinant Therapeutic Protein Market Share by Application in 2019
Figure 39. Europe Recombinant Therapeutic Protein Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Recombinant Therapeutic Protein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Recombinant Therapeutic Protein Sales Market Share by Country in 2019
Figure 42. Europe Recombinant Therapeutic Protein Revenue Market Share by Country in 2019
Figure 43. Germany Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Recombinant Therapeutic Protein Market Share by Type in 2019
Figure 54. Europe Recombinant Therapeutic Protein Market Share by Application in 2019
Figure 55. Asia Pacific Recombinant Therapeutic Protein Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Recombinant Therapeutic Protein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Recombinant Therapeutic Protein Sales Market Share by Region in 2019
Figure 58. Asia Pacific Recombinant Therapeutic Protein Revenue Market Share by Region in 2019
Figure 59. China Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Recombinant Therapeutic Protein Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Recombinant Therapeutic Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Recombinant Therapeutic Protein Market Share by Type in 2019
Figure 82. Asia Pacific Recombinant Therapeutic Protein Market Share by Application in 2019
Figure 83. Latin America Recombinant Therapeutic Pro

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs